Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
Retinal gene therapy is increasingly recognized as a novel molecular intervention that has huge potential in treating common causes of blindness, the majority of which have a genetic aetiology1,2,3,4,5. Choroideremia is a chronic X-linked retinal degeneration that was first described in 18726. It le...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Springer Nature
2018
|
| _version_ | 1797069035684233216 |
|---|---|
| author | Xue, K Jolly, J Barnard, A Rudenko, A Salvetti, A Patrício, M Edwards, T Groppe, M Orlans, H Tolmachova, T Black, G Webster, A Lotery, A Holder, G Downes, S Seabra, M MacLaren, R |
| author_facet | Xue, K Jolly, J Barnard, A Rudenko, A Salvetti, A Patrício, M Edwards, T Groppe, M Orlans, H Tolmachova, T Black, G Webster, A Lotery, A Holder, G Downes, S Seabra, M MacLaren, R |
| author_sort | Xue, K |
| collection | OXFORD |
| description | Retinal gene therapy is increasingly recognized as a novel molecular intervention that has huge potential in treating common causes of blindness, the majority of which have a genetic aetiology1,2,3,4,5. Choroideremia is a chronic X-linked retinal degeneration that was first described in 18726. It leads to progressive blindness due to deficiency of Rab-escort protein 1 (REP1). We designed an adeno-associated viral vector to express REP1 and assessed it in a gene therapy clinical trial by subretinal injection in 14 patients with choroideremia. The primary endpoint was vision change in treated eyes 2 years after surgery compared to unoperated fellow eyes. Despite complications in two patients, visual acuity improved in the 14 treated eyes over controls (median 4.5 letter gain, versus 1.5 letter loss, P = 0.04), with 6 treated eyes gaining more than one line of vision (>5 letters). The results suggest that retinal gene therapy can sustain and improve visual acuity in a cohort of predominantly late-stage choroideremia patients in whom rapid visual acuity loss would ordinarily be predicted. |
| first_indexed | 2024-03-06T22:18:40Z |
| format | Journal article |
| id | oxford-uuid:54465eca-31ec-4541-84ea-4fb93ffb56cf |
| institution | University of Oxford |
| last_indexed | 2024-03-06T22:18:40Z |
| publishDate | 2018 |
| publisher | Springer Nature |
| record_format | dspace |
| spelling | oxford-uuid:54465eca-31ec-4541-84ea-4fb93ffb56cf2022-03-26T16:36:51ZBeneficial effects on vision in patients undergoing retinal gene therapy for choroideremiaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:54465eca-31ec-4541-84ea-4fb93ffb56cfSymplectic Elements at OxfordSpringer Nature2018Xue, KJolly, JBarnard, ARudenko, ASalvetti, APatrício, MEdwards, TGroppe, MOrlans, HTolmachova, TBlack, GWebster, ALotery, AHolder, GDownes, SSeabra, MMacLaren, RRetinal gene therapy is increasingly recognized as a novel molecular intervention that has huge potential in treating common causes of blindness, the majority of which have a genetic aetiology1,2,3,4,5. Choroideremia is a chronic X-linked retinal degeneration that was first described in 18726. It leads to progressive blindness due to deficiency of Rab-escort protein 1 (REP1). We designed an adeno-associated viral vector to express REP1 and assessed it in a gene therapy clinical trial by subretinal injection in 14 patients with choroideremia. The primary endpoint was vision change in treated eyes 2 years after surgery compared to unoperated fellow eyes. Despite complications in two patients, visual acuity improved in the 14 treated eyes over controls (median 4.5 letter gain, versus 1.5 letter loss, P = 0.04), with 6 treated eyes gaining more than one line of vision (>5 letters). The results suggest that retinal gene therapy can sustain and improve visual acuity in a cohort of predominantly late-stage choroideremia patients in whom rapid visual acuity loss would ordinarily be predicted. |
| spellingShingle | Xue, K Jolly, J Barnard, A Rudenko, A Salvetti, A Patrício, M Edwards, T Groppe, M Orlans, H Tolmachova, T Black, G Webster, A Lotery, A Holder, G Downes, S Seabra, M MacLaren, R Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia |
| title | Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia |
| title_full | Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia |
| title_fullStr | Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia |
| title_full_unstemmed | Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia |
| title_short | Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia |
| title_sort | beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia |
| work_keys_str_mv | AT xuek beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT jollyj beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT barnarda beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT rudenkoa beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT salvettia beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT patriciom beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT edwardst beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT groppem beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT orlansh beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT tolmachovat beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT blackg beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT webstera beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT loterya beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT holderg beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT downess beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT seabram beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia AT maclarenr beneficialeffectsonvisioninpatientsundergoingretinalgenetherapyforchoroideremia |